Share on StockTwits

MedAssets (NASDAQ:MDAS) was upgraded by Leerink Swann from a “market perform” rating to an “outperform” rating in a research note issued on Tuesday, TheFlyOnTheWall.com reports.

Shares of MedAssets (NASDAQ:MDAS) opened at 21.25 on Tuesday. MedAssets has a 52-week low of $19.38 and a 52-week high of $26.58. The stock’s 50-day moving average is $22.71 and its 200-day moving average is $23.16. The company has a market cap of $1.277 billion and a P/E ratio of 45.09.

MedAssets (NASDAQ:MDAS) last announced its earnings results on Wednesday, July 30th. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.29 by $0.01. The company had revenue of $175.42 million for the quarter, compared to the consensus estimate of $175.70 million. During the same quarter in the prior year, the company posted $0.30 earnings per share. The company’s quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts predict that MedAssets will post $1.34 earnings per share for the current fiscal year.

MDAS has been the subject of a number of other recent research reports. Analysts at Raymond James reiterated an “outperform” rating on shares of MedAssets in a research note on Thursday, July 31st. They now have a $27.50 price target on the stock, up previously from $25.00. Separately, analysts at Citigroup Inc. downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 29th. They now have a $26.00 price target on the stock, down previously from $28.00. Finally, analysts at Bank of America downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 22nd. They now have a $24.00 price target on the stock, down previously from $25.00. Eleven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $25.66.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.